Seven Eight Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-90,195
Closed -$5.95M 207
2024
Q3
$5.95M Buy
+90,195
New +$5.95M 0.53% 16
2024
Q2
Sell
-17,613
Closed -$1.68M 759
2024
Q1
$1.68M Buy
17,613
+441
+3% +$42.1K 0.18% 174
2023
Q4
$1.31M Sell
17,172
-159,956
-90% -$12.2M 0.15% 198
2023
Q3
$12.3M Buy
177,128
+169,746
+2,299% +$11.8M 1.44% 1
2023
Q2
$696K Sell
7,382
-20,930
-74% -$1.97M 0.12% 243
2023
Q1
$2.34M Buy
28,312
+9,625
+52% +$796K 0.49% 45
2022
Q4
$1.39M Sell
18,687
-78,117
-81% -$5.83M 0.36% 83
2022
Q3
$7.88M Buy
+96,804
New +$7.88M 1.58% 1
2022
Q2
Sell
-3,228
Closed -$380K 452
2022
Q1
$380K Buy
+3,228
New +$380K 0.05% 367
2021
Q4
Sell
-27,124
Closed -$3.07M 533
2021
Q3
$3.07M Buy
27,124
+13,300
+96% +$1.51M 0.3% 104
2021
Q2
$1.43M Buy
+13,824
New +$1.43M 0.2% 167
2020
Q4
Sell
-6,200
Closed -$495K 477
2020
Q3
$495K Sell
6,200
-7,200
-54% -$575K 0.11% 342
2020
Q2
$939K Sell
13,400
-35,200
-72% -$2.47M 0.69% 22
2020
Q1
$3.06M Sell
48,600
-121,587
-71% -$7.65M 0.79% 23
2019
Q4
$13.2M Buy
170,187
+110,700
+186% +$8.61M 0.7% 16
2019
Q3
$4.36M Buy
+59,487
New +$4.36M 0.23% 125
2019
Q2
Sell
-144,087
Closed -$9.19M 631
2019
Q1
$9.19M Buy
+144,087
New +$9.19M 0.49% 53
2018
Q1
Sell
-141,987
Closed -$5.33M 418
2017
Q4
$5.33M Buy
141,987
+10,176
+8% +$382K 0.54% 45
2017
Q3
$4.8M Buy
+131,811
New +$4.8M 0.59% 45
2017
Q2
Sell
-39,111
Closed -$1.23M 593
2017
Q1
$1.23M Sell
39,111
-12,444
-24% -$390K 0.24% 148
2016
Q4
$1.61M Buy
+51,555
New +$1.61M 0.32% 101
2016
Q3
Sell
-76,800
Closed -$2.55M 407
2016
Q2
$2.55M Buy
76,800
+49,200
+178% +$1.64M 0.88% 14
2016
Q1
$812K Buy
27,600
+14,400
+109% +$424K 0.35% 99
2015
Q4
$348K Buy
+13,200
New +$348K 0.24% 151
2015
Q3
Sell
-4,800
Closed -$114K 580
2015
Q2
$114K Buy
4,800
+4,200
+700% +$99.8K 0.13% 248
2015
Q1
$14K Buy
+600
New +$14K 0.02% 376
2014
Q2
Sell
-31,200
Closed -$386K 540
2014
Q1
$386K Buy
+31,200
New +$386K 0.33% 105